Influenza
Showing NaN - NaN of 63
Influenza Trial in Worldwide (40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo)
Completed
- Influenza
- 40 mg Laninamivir Octanoate
- +2 more
-
Scottsboro, Alabama
- +220 more
May 29, 2018
Acute Respiratory Infection Consortium
Unknown status
- Influenza
-
San Diego, California
- +5 more
Dec 22, 2016
Influenza Trial in Finland, United States (Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV), non-adjuvanted
Completed
- Influenza
- Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)
- non-adjuvanted Quadrivalent Influenza Vaccine (QIV)
-
San Diego, California
- +27 more
Oct 26, 2016
Influenza Trial in United States (Intravenous hyperimmune immunoglobulin (Flu-IVIG), Placebo)
Completed
- Influenza
- Intravenous hyperimmune immunoglobulin (Flu-IVIG)
- Placebo
-
San Diego, California
- +10 more
Aug 12, 2016
Influenza, Myxovirus Infection Trial in United States (Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation
Completed
- Influenza
- Myxovirus Infection
- Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)
- +3 more
-
Alabaster, Alabama
- +28 more
Apr 12, 2016
Influenza Trial in Puerto Rico, United States (Influenza Virus Vaccine USP Trivalent Types A and B)
Completed
- Influenza
- Influenza Virus Vaccine USP Trivalent Types A and B
-
Hoover, Alabama
- +44 more
Apr 12, 2016
Orthomyxoviridae Infection, Influenza, Myxovirus Infection Trial in United States (High-Dose Inactivated, Split-Virion Influenza
Completed
- Orthomyxoviridae Infection
- +2 more
- High-Dose Inactivated, Split-Virion Influenza Vaccine
- Inactivated, Split-Virion Influenza Vaccine
-
Mesa, Arizona
- +27 more
Apr 12, 2016
Orthomyxoviridae Infection, Influenza, Myxovirus Infection Trial in Puerto Rico, United States (Influenza Virus Vaccine USP
Completed
- Orthomyxoviridae Infection
- +2 more
- Influenza Virus Vaccine USP Trivalent Types A and B
-
Hoover, Alabama
- +48 more
Apr 12, 2016
Influenza Trial in Worldwide (Favipiravir, Placebo comparator)
Influenza Trial in United States (Vero cell-derived, trivalent, seasonal influenza vaccine, Placebo: Phosphate-buffered saline)
Completed
- Influenza
- Vero cell-derived, trivalent, seasonal influenza vaccine
- Placebo: Phosphate-buffered saline
-
Tucson, Arizona
- +35 more
Oct 7, 2015
Influenza Trial in United States (Vero cell derived, trivalent, seasonal influenza vaccine, Licensed egg-derived, trivalent
Completed
- Influenza
- Vero cell derived, trivalent, seasonal influenza vaccine
- Licensed egg-derived, trivalent seasonal influenza vaccine
-
Mobile, Alabama
- +29 more
Oct 7, 2015
Influenza Trial in United States (Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative, Investigational Trivalent
Completed
- Influenza
- Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative
- +2 more
-
Dothan, Alabama
- +66 more
Jun 16, 2015
Influenza Trial in United States (VAX2012Q, Fluzone Quadrivalent)
Unknown status
- Influenza
- VAX2012Q
- Fluzone Quadrivalent
-
Huntsville, Alabama
- +5 more
Jun 25, 2015
Influenza Trial in United States (Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation,
Completed
- Influenza
- Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation
- +2 more
-
Hoover, Alabama
- +37 more
Apr 20, 2015
Influenza Trial in Canada, Puerto Rico, United States (High Dose Trivalent Inactivated Influenza Vaccine, Trivalent Inactivated
Completed
- Influenza
- High Dose Trivalent Inactivated Influenza Vaccine
- Trivalent Inactivated Influenza Vaccine
-
Mobile, Alabama
- +112 more
Mar 30, 2015
Influenza Trial in United States (Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing
Completed
- Influenza
- Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing process (VCIV modified)
- +2 more
-
Chandler, Arizona
- +19 more
Jun 27, 2014